RT Journal Article
SR Electronic
T1 The impact of assortative mating, participation bias, and socioeconomic status on the polygenic risk of behavioral and psychiatric traits
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.11.29.22282912
DO 10.1101/2022.11.29.22282912
A1 Cabrera-Mendoza, Brenda
A1 Wendt, Frank R
A1 Pathak, Gita A
A1 Yengo, Loic
A1 Polimanti, Renato
YR 2022
UL http://medrxiv.org/content/early/2022/11/30/2022.11.29.22282912.abstract
AB To investigate assortative mating (AM), participation bias, and socioeconomic status (SES) with respect to the genetics of behavioral and psychiatric traits, we analyzed gametic phase disequilibrium (GPD), within-spouses and within-siblings polygenic risk score (PRS) correlation, performing a SES conditional analysis. We observed genetic signatures of AM across multiple methods for traits related to substance use with SES conditioning increasing the within-spouses PRS correlation for Frequency of drinking alcohol (2.5% to 6%), Maximum habitual alcohol intake (1.33% to 4.43%), and Ever taken cannabis (1.5% to 5.3%). Comparing UK Biobank mental health questionnaire responders vs. non-responders, major depressive disorder PRS showed significant GPD in both groups when based on the Million Veteran Program (3.2% vs. 3%), but only in responders when based on the Psychiatric Genomics Consortium (3.8% vs. 0.2%). These results highlight the impact of AM, participation bias, and SES on the polygenic risk of behavioral and psychiatric traits.Competing Interest StatementDr. Polimanti is paid for their editorial work on the journal Complex Psychiatry and reports a research grant from Alkermes. The other authors declare no competing interests.Funding StatementThe authors acknowledge support from the National Institutes of Health (R21 DC018098, R33 DA047527, RF1 MH132337, and K99 AG078503), One Mind, and the American Foundation for Suicide Prevention (PDF-1-022-21).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All GWAS data are publicly available on their respective websites. UK Biobank, https://www.ukbiobank.ac.uk/enable-your-research/apply-for-access Psychiatric Genomics Consortium, https://pgc.unc.edu/for-researchers/download-results/ Million Veteran Program, https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001672.v8.p1I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll results used to make conclusions discussed in this study are provided as Supplementary Material.